189 related articles for article (PubMed ID: 25946369)
21. Prevalence and predictors of influenza and pneumococcal vaccine uptake in patients with diabetes.
Clancy U; Moran I; Tuthill A
Ir Med J; 2012 Oct; 105(9):298-300. PubMed ID: 23240281
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological characteristics associated with uptake of pneumococcal vaccine among older adults living in the community in Singapore: Results from the National Health Surveillance Survey 2013.
Ang LW; Cutter J; James L; Goh KT
Scand J Public Health; 2018 Mar; 46(2):175-181. PubMed ID: 28701087
[TBL] [Abstract][Full Text] [Related]
23. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.
Vila-Corcoles A; Ochoa-Gondar O
Expert Rev Vaccines; 2012 Feb; 11(2):221-36. PubMed ID: 22309670
[TBL] [Abstract][Full Text] [Related]
24. Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).
Chan TC; Hung IF; Luk JK; Shea YF; Chan FH; Woo PC; Chu LW
J Am Med Dir Assoc; 2012 Oct; 13(8):698-703. PubMed ID: 22722051
[TBL] [Abstract][Full Text] [Related]
25. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention?
Arencibia Jiménez M; Navarro Gracia JF; Delgado de Los Reyes JA; Pérez Torregrosa G; López Parra D; López García P
Arch Bronconeumol; 2014 Mar; 50(3):93-8. PubMed ID: 24315186
[TBL] [Abstract][Full Text] [Related]
26. Immunization after renal transplantation: current clinical practice.
Struijk GH; Lammers AJ; Brinkman RJ; Lombarts MJ; van Vugt M; van der Pant KA; Ten Berge IJ; Bemelman FJ
Transpl Infect Dis; 2015 Apr; 17(2):192-200. PubMed ID: 25662181
[TBL] [Abstract][Full Text] [Related]
27. Review: clinical inertia in the management of chronic obstructive pulmonary disease.
Cooke CE; Sidel M; Belletti DA; Fuhlbrigge AL
COPD; 2012 Feb; 9(1):73-80. PubMed ID: 22292599
[TBL] [Abstract][Full Text] [Related]
28. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
[TBL] [Abstract][Full Text] [Related]
29. Determinants of influenza vaccination among the adult and older Italian population with chronic obstructive pulmonary disease: a secondary analysis of the multipurpose ISTAT survey on health and health care use.
Chiatti C; Barbadoro P; Marigliano A; Ricciardi A; Di Stanislao F; Prospero E
Hum Vaccin; 2011 Oct; 7(10):1021-5. PubMed ID: 21941094
[TBL] [Abstract][Full Text] [Related]
30. Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs.
Grogg SE; Schultz J
J Am Osteopath Assoc; 2015 Jun; 115(6 Suppl):S6-25. PubMed ID: 26000904
[TBL] [Abstract][Full Text] [Related]
31. [Vaccination against pneumococcal infection in adults].
Viejo JL
Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():26-8. PubMed ID: 20084346
[No Abstract] [Full Text] [Related]
32. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
Taitel M; Cohen E; Duncan I; Pegus C
Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
[TBL] [Abstract][Full Text] [Related]
33. Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study.
Jackson LA; Baxter R; Naleway AL; Belongia EA; Baggs J
BMC Infect Dis; 2009 Mar; 9():37. PubMed ID: 19321001
[TBL] [Abstract][Full Text] [Related]
34. Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria.
Andrews RM; Skull SA; Byrnes GB; Campbell DA; Turner JL; McIntyre PB; Kelly HA
Commun Dis Intell Q Rep; 2005; 29(3):283-8. PubMed ID: 16220865
[TBL] [Abstract][Full Text] [Related]
35. Eight years of active proposal of pneumococcal 23-valent polysaccharide vaccine: survey on coverage rate among elderly and chronic patients.
Martinelli D; Tafuri S; Caputi G; Fortunato F; Reggio P; Germinario C; Prato R
Am J Infect Control; 2010 May; 38(4):e8-e15. PubMed ID: 20211508
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study.
Ochoa-Gondar O; Hospital I; Vila-Corcoles A; Aragon M; Jariod M; de Diego C; Satue E;
BMC Public Health; 2017 Jun; 17(1):610. PubMed ID: 28662648
[TBL] [Abstract][Full Text] [Related]
37. Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based study.
Kaszuba E; Odeberg H; Råstam L; Halling A
BMC Res Notes; 2016 Apr; 9():215. PubMed ID: 27067412
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of influenza vaccination and pneumococcal vaccination in elderly and high-risk patients seen in a university general medicine clinic.
Lai H; Aronow WS; Gutwein AH
Am J Ther; 2008; 15(6):528-30. PubMed ID: 19127136
[TBL] [Abstract][Full Text] [Related]
39. [The clinical aspects of efficiency of the prevention of pneumococcal infection with vaccines in chronic obstructive pulmonary disease patients living in the West Siberian Region].
Kostinov MP; Ryzhov AA; Magarshak OO; Zhirova SN; Protasov AD; Erofeev IuV; Migunova OV; Tolokonnikova IN; Liverko EV
Ter Arkh; 2014; 86(3):28-33. PubMed ID: 24779067
[TBL] [Abstract][Full Text] [Related]
40. Patient and physician factors associated with pulmonary function testing for COPD: a population study.
Gershon AS; Hwee J; Croxford R; Aaron SD; To T
Chest; 2014 Feb; 145(2):272-281. PubMed ID: 24008897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
